Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients.

S Pol, M Bourliere, S Lucier, Christophe HEZODE, C Dorival, D Larrey, JP Bronowicki, VD Ledinghen, F Zoulim, A Tran, S Metivier, JP Zarski, D Samuel, D Guyader, P Marcellin, A Minello, L Alric, D Thabut, O Chazouilleres, G Riachi, V Bourcier, P Mathurin, V Loustaud-Ratti, L D'Alteroche, I Fouchard-Hubert, F Habersetzer, X Causse, C Geist, I Rosa, J Gournay, E Saillard, E Billaud, V Petrov-Sanchez, A Diallo, H Fontaine, F Carrat,

J Hepatol. 01/01/2017;66(1) : 39-47 10.1016/j.jhep.2016.08.021 10/09/2016

Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection.

JJ Feld, IM Jacobson, MS Sulkowski, F Poordad, F Tatsch, Jean-Michel PAWLOTSKY,

Liver Int. 01/01/2017;37(1) : 5-18 10.1111/liv.13212 29/09/2016

Quality of life 10 years after liver transplantation: The impact of graft histology.

V Karam, M Sebagh, K Rifai, F Yilmaz, P Bhangui, C Danet, F Saliba, D Samuel, D Castaing, R Adam, Cyrille FERAY,

World J Transplant. 24/12/2016;6(4) : 703-711 10.5500/wjt.v6.i4.703.

Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features.

Julien CALDERARO, Benoit ROUSSEAU, Giuliana AMADDEO, M Mercey, C Charpy, CE Costentin, Alain LUCIANI, ES Zafrani, A Laurent, D Azoulay, Fouad LAFDIL, Jean-Michel PAWLOTSKY,

Hepatology 01/12/2016;64(6) : 2038-2046 10.1002/hep.28710. 09/08/2016

Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation

N De'Angelis, F Landi, M Nencioni, A Palen, E Lahat, C Salloum, P Compagnon, C Lim, C Costentin, Julien CALDERARO, Alain LUCIANI, Cyrille FERAY, D Azoulay,

Prog Transplant. 01/12/2016;26(4) : 348-355 10.1177/1526924816664083. 20/09/2016

Albumin Dialysis as a Bridge From Total Hepatectomy to Liver Transplantation for Fulminant Hepatitis With Toxic Syndrome.

E Levesque, D Azoulay, Cyrille FERAY, G Dhonneur,

Ther Apher Dial. 01/12/2016;20(6) : 692-693 10.1111/1744-9987.12455. 15/09/2016

Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression

S Rebouissou, A Franconi, Julien CALDERARO, E Letouze, S Imbeaud, C Pilati, JC Nault, G Couchy, A Laurent, C Balabaud, P Bioulac-Sage, J Zucman-Rossi,

Hepatology 01/12/2016;64(6) : 2047-2061 10.1002/hep.28638. 11/06/2016

The end of the hepatitis C burden: Really?

Jean-Michel PAWLOTSKY,

Hepatology 01/11/2016;64(5) : 1404-1407 10.1002/hep.28758. 25/08/2016

First-line antiangiogenics for metastatic renal cell carcinoma: A systematic review and network meta-analysis

Benoit ROUSSEAU, E Kempf, G Desamericq, E Boissier, M Chaubet-Houdu, C Joly, C Saldana, H Boussion, C Neuzillet, I Macquin-Mavier, S Oudard, L Salomon, A de la Taille, C Tournigand,

Crit Rev Oncol Hematol. 01/11/2016;107 : 44-53 10.1016/j.critrevonc.2016.08.012. 01/09/2016

IQGAP2 is a novel interferon-alpha antiviral effector gene acting non-conventionally through the NF-κB pathway.

C Brisac, S Salloum, V Yang, EA Schaefer, JA Holmes, Stephane CHEVALIEZ, J Hong, C Carlton-Smith, N Alatrakchi, A Kruger, W Lin, RT Chung,

J Hepatol. 01/11/2016;65(5) : 972-979 10.1016/j.jhep.2016.06.028. 09/07/2016